BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16569781)

  • 1. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience.
    Chen CY; Li CW; Kuo YT; Jaw TS; Wu DK; Jao JC; Hsu JS; Liu GC
    Radiology; 2006 May; 239(2):448-56. PubMed ID: 16569781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
    J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
    Larson AC; Wang D; Atassi B; Sato KT; Ryu RK; Lewandowski RJ; Nemcek AA; Mulcahy MF; Kulik LM; Miller FH; Salem R; Omary RA
    Radiology; 2008 Mar; 246(3):964-71. PubMed ID: 18309018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Tsuge Y; Shiratori Y; Onozuka M; Moriyama N
    J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy on hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Bian DJ; Xiao EH; Hu DX; Chen XY; Situ WJ; Yuan SW; Sun JL; Yang LP
    Chin J Cancer; 2010 Feb; 29(2):198-201. PubMed ID: 20109351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
    Yuan Z; Ye XD; Dong S; Xu LC; Xiao XS
    J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response.
    Halappa VG; Bonekamp S; Corona-Villalobos CP; Li Z; Mensa M; Reyes D; Eng J; Bhagat N; Pawlik TM; Geschwind JF; Kamel IR
    Radiology; 2012 Jul; 264(1):285-94. PubMed ID: 22627601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ; Zhang L; Ouyang YS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome.
    Vandecaveye V; Michielsen K; De Keyzer F; Laleman W; Komuta M; Op de beeck K; Roskams T; Nevens F; Verslype C; Maleux G
    Radiology; 2014 Mar; 270(3):747-57. PubMed ID: 24475816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
    Mannelli L; Kim S; Hajdu CH; Babb JS; Taouli B
    Eur J Radiol; 2013 Apr; 82(4):577-82. PubMed ID: 23246330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diaphragmatic weakness after transcatheter arterial chemoembolization of inferior phrenic artery for treatment of hepatocellular carcinoma.
    Shin SW; Do YS; Choo SW; Lieu WC; Cho SK; Park KB; Yoo BC; Kang EH; Choo IW
    Radiology; 2006 Nov; 241(2):581-8. PubMed ID: 17005772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
    Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
    Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.
    Kokabi N; Camacho JC; Xing M; Edalat F; Mittal PK; Kim HS
    J Magn Reson Imaging; 2015 Oct; 42(4):981-9. PubMed ID: 25683022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging.
    Chen X; Xiao E; Shu D; Yang C; Liang B; He Z; Bian D
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):109-13. PubMed ID: 24284371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of resection following downstaging of unresectable hepatocelluar carcinoma by transcatheter arterial chemoembolization.
    Shi XJ; Jin X; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
    Chin Med J (Engl); 2012 Jan; 125(2):197-202. PubMed ID: 22340545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo 1H magnetic resonance spectroscopy in evaluation of hepatocellular carcinoma and its early response to transcatheter arterial chemoembolization.
    Wu B; Peng WJ; Wang PJ; Gu YJ; Li WT; Zhou LP; Tang F; Zhong GM
    Chin Med Sci J; 2006 Dec; 21(4):258-64. PubMed ID: 17249202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
    Kimura S; Okazaki M; Higashihara H; Haruno M; Nozaki Y; Urakawa H; Kora S; Shinagawa Y; Nonokuma M
    Hepatogastroenterology; 2009; 56(89):191-8. PubMed ID: 19453056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
    Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
    Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.